| 000 | 01700 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517210825.0 | ||
| 264 | 0 | _c20180921 | |
| 008 | 201809s 0 0 eng d | ||
| 022 | _a1791-2431 | ||
| 024 | 7 |
_a10.3892/or.2018.6344 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSang, Meijie | |
| 245 | 0 | 0 |
_aImpact of RUNX2 gene silencing on the gemcitabine sensitivity of p53‑mutated pancreatic cancer MiaPaCa‑2 spheres. _h[electronic resource] |
| 260 |
_bOncology reports _cJun 2018 |
||
| 300 |
_a2749-2758 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aCell Culture Techniques |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCore Binding Factor Alpha 1 Subunit _xgenetics |
| 650 | 0 | 4 |
_aDeoxycytidine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 |
_aGene Regulatory Networks _xdrug effects |
| 650 | 0 | 4 | _aGene Silencing |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aSpheroids, Cellular _xcytology |
| 650 | 0 | 4 |
_aTranscription Factors _xgenetics |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xgenetics |
| 650 | 0 | 4 |
_aTumor Suppressor Proteins _xgenetics |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aNakamura, Mizuyo | |
| 700 | 1 | _aOgata, Takehiro | |
| 700 | 1 | _aSun, Dan | |
| 700 | 1 | _aShimozato, Osamu | |
| 700 | 1 | _aNikaido, Toshio | |
| 700 | 1 | _aOzaki, Toshinori | |
| 773 | 0 |
_tOncology reports _gvol. 39 _gno. 6 _gp. 2749-2758 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3892/or.2018.6344 _zAvailable from publisher's website |
| 999 |
_c28253032 _d28253032 |
||